Literature DB >> 16482205

Typical and atypical trafficking pathways of Ad5 penton base recombinant protein: implications for gene transfer.

A Rentsendorj1, J Xie, M MacVeigh, H Agadjanian, S Bass, D-H Kim, J Rossi, S F Hamm-Alvarez, L K Medina-Kauwe.   

Abstract

The adenovirus (Ad) penton base protein facilitates viral infection by binding cell surface integrins, triggering receptor-mediated endocytosis and mediating endosomal penetration. Given these multiple functions, recombinant penton base proteins have been utilized as non-viral vehicles for gene transfer by our lab and others. Although we have previously demonstrated that penton base-derived vectors undergo integrin-specific binding and cell entry, less than desirable levels of gene expression have led us to re-evaluate the recombinant penton base as an agent for gene delivery. To do so, we have examined here the intracellular trafficking of an Ad serotype 5 (Ad5) recombinant penton base protein (PB). Here, we not only observed that PB utilizes a similar, typical trafficking pathway of whole Ad, but also found that PB entered HeLa cells through pathways not yet identified as contributing to cell entry by the whole virus. We show by high-resolution confocal microscopy and biochemical methods that binding to alphav-integrins is a requirement for cell entry, but that early internalization stages did not substantially pass through clathrin-positive and early endosomal compartments. Moreover, a subpopulation of internalized protein localized with caveolin-positive compartments and Golgi markers, suggesting that a certain percentage of proteins pass through non-clathrin-mediated pathways. Similar to the virus, trafficking toward the nucleus was affected by disruption of microtubules and dynein. The majority of penton base molecules avoided the lysosome while facilitating early vesicle release of low molecular weight dextran molecules. In further support of a vesicle escape capacity, a subpopulation of internalized penton base appeared to enter the nucleus, as observed by high-resolution confocal microscopy and cell fractionation. As a confirmation of these findings, we demonstrate that a recombinant penton base facilitated cytosolic entry of an siRNA molecule as observed by RNA interference of a marker gene. Based on our findings here, we suggest that whereas soluble penton base proteins may enter cells through clathrin- and non-clathrin-mediated pathways, vesicle escape and nuclear delivery appear to be supported by a clathrin-mediated pathway. As our previous efforts have focused on utilizing recombinant penton base proteins as delivery agents for therapeutics, these findings allow us to evaluate the use of the penton base as a cell entry and intracellular trafficking agent, and may be of interest concerning the development of vectors for efficient delivery of therapeutics to cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16482205     DOI: 10.1038/sj.gt.3302729

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  13 in total

Review 1.  Viral vectors: from virology to transgene expression.

Authors:  D Bouard; D Alazard-Dany; F-L Cosset
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

2.  Chemotherapy targeting by DNA capture in viral protein particles.

Authors:  Hasmik Agadjanian; David Chu; Jae Youn Hwang; Sebastian Wachsmann-Hogiu; Altan Rentsendorj; Lei Song; Vinod Valluripalli; Jay Lubow; Jun Ma; Behrooz Sharifi; Daniel L Farkas; Lali K Medina-Kauwe
Journal:  Nanomedicine (Lond)       Date:  2012-03       Impact factor: 5.307

3.  A mechanistic study of tumor-targeted corrole toxicity.

Authors:  Jae Youn Hwang; Jay Lubow; David Chu; Jun Ma; Hasmik Agadjanian; Jessica Sims; Harry B Gray; Zeev Gross; Daniel L Farkas; Lali K Medina-Kauwe
Journal:  Mol Pharm       Date:  2011-10-25       Impact factor: 4.939

4.  Novel fiber-dependent entry mechanism for adenovirus serotype 5 in lacrimal acini.

Authors:  Jiansong Xie; Lilian Chiang; Janette Contreras; Kaijin Wu; Judy A Garner; Lali Medina-Kauwe; Sarah F Hamm-Alvarez
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

5.  Analysis of targeted viral protein nanoparticles delivered to HER2+ tumors.

Authors:  Jae Youn Hwang; Daniel L Farkas; Lali K Medina-Kauwe
Journal:  J Vis Exp       Date:  2013-06-18       Impact factor: 1.355

Review 6.  Development of adenovirus capsid proteins for targeted therapeutic delivery.

Authors:  Lali K Medina-Kauwe
Journal:  Ther Deliv       Date:  2013-02

7.  A corrole nanobiologic elicits tissue-activated MRI contrast enhancement and tumor-targeted toxicity.

Authors:  Jessica D Sims; Jae Youn Hwang; Shawn Wagner; Felix Alonso-Valenteen; Chris Hanson; Jan Michael Taguiam; Richard Polo; Ira Harutyunyan; Gevorg Karapetyan; Karn Sorasaenee; Ahmed Ibrahim; Eduardo Marban; Rex Moats; Harry B Gray; Zeev Gross; Lali K Medina-Kauwe
Journal:  J Control Release       Date:  2015-08-31       Impact factor: 9.776

8.  Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics.

Authors:  Jessica D Sims; Jan Michael Taguiam; Felix Alonso-Valenteen; Janet Markman; Hasmik Agadjanian; David Chu; Jay Lubow; Ravinder Abrol; Dustin Srinivas; Anjali Jain; Bingchen Han; Ying Qu; Parisa Mirzadehgan; Jae-Youn Hwang; Altan Rentsendorj; Alice Chung; Jenny Lester; Beth Y Karlan; Harry B Gray; Zeev Gross; Armando Giuliano; Xiaojiang Cui; Lali K Medina-Kauwe
Journal:  J Control Release       Date:  2017-12-27       Impact factor: 11.467

9.  Liposome-mediated cellular delivery of active gp91(phox).

Authors:  Bruno Marques; Lavinia Liguori; Marie-Hélène Paclet; Ana Villegas-Mendéz; Romy Rothe; Françoise Morel; Jean-Luc Lenormand
Journal:  PLoS One       Date:  2007-09-12       Impact factor: 3.240

Review 10.  "Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?

Authors:  L K Medina-Kauwe
Journal:  Adv Drug Deliv Rev       Date:  2007-07-05       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.